What Is Peptide Therapy? Complete Beginner's Guide (2026)

Executive Summary

Peptide therapy sits at the intersection of longevity medicine, men's health, and performance optimization — but most of what you find online is either academic jargon or clinic marketing. This guide is neither. It is a practical, evidence-grounded introduction written for someone who is hearing about peptides seriously for the first time and wants a clear picture before spending money.

The short version: peptides are short chains of amino acids — smaller than proteins — that act as signaling molecules in the body. Your body already produces hundreds of them. Therapeutic peptides are either identical to natural human peptides or structurally similar analogs designed to produce a specific biological effect. Unlike anabolic steroids, which override the body's hormonal system, most therapeutic peptides work by amplifying signals the body already uses. That distinction matters for both efficacy and safety.

This guide covers what peptides are, the most common therapeutic types and what they are actually used for, who is a good candidate, how to get started safely, what it costs in 2026, and how to choose between the clinics that prescribe them. Use the navigation below to jump to the section most relevant to your situation.

At-a-Glance Comparison

Overview of the main peptide therapy categories used in clinical telehealth in 2026. Cost is medication only; add $50–$150/month for clinic fees, labs, and consultations.

What is peptide therapy, exactly?

Peptide therapy is the therapeutic use of short amino acid chains — called peptides — to achieve a specific biological effect. Unlike drugs that block pathways or override systems, most therapeutic peptides work by mimicking or amplifying signals the body already uses naturally. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Peptides are defined by their size: shorter than proteins (typically 2–50 amino acids) but longer than individual amino acids. They are naturally produced throughout the body and serve as signaling molecules — telling cells to release hormones, repair tissue, regulate inflammation, or modulate immune function.

Why peptides instead of the hormone itself? Consider growth hormone (GH) as an example. Injecting synthetic GH directly works, but it bypasses the body's feedback mechanisms, can suppress natural production, and carries a significant regulatory and cost burden. Growth hormone secretagogues (GHS) — peptides like sermorelin, ipamorelin, and CJC-1295 — instead stimulate the pituitary gland to release its own GH using its own regulatory rhythm. The body's natural feedback loops remain intact. This is why GHS peptides tend to produce more physiologically natural GH pulses and a safer side-effect profile than direct GH administration.

The regulatory context in 2026: Many therapeutic peptides exist in a complex regulatory space. Some are FDA-approved drugs (semaglutide as Ozempic/Wegovy, tirzepatide as Mounjaro/Zepbound, PT-141 as Vyleesi). Others are prescribed as compounded medications through licensed 503A or 503B compounding pharmacies under a physician's order. Others occupy research gray areas and are not legitimately prescribable. Understanding which category a peptide falls into is an important part of evaluating whether a clinic is operating legitimately — any clinic that prescribes or ships peptides without a genuine physician consultation and valid prescription should be a hard pass.

For a broad overview of the safety and regulatory landscape, see peptide therapy side effects and safety guide. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: conflating all 'peptides' as equivalent. The category spans FDA-approved medications with robust clinical trials, legitimate compounded therapies with solid evidence, and unscheduled research compounds sold without proper oversight. Each tier has a meaningfully different risk and legitimacy profile. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Types of peptides: what each category does and who it is for

Peptides are not interchangeable. Different categories act on entirely different biological systems and are appropriate for different goals, health profiles, and risk tolerances. Choosing the right category is the first decision a beginner needs to make. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

1. Growth Hormone Secretagogues (GHS) — the most commonly prescribed category
The GHS category includes sermorelin, ipamorelin, CJC-1295 (with and without DAA), and tesamorelin. All of them stimulate the pituitary to release GH via different receptor mechanisms. They are commonly used for:
— Body composition improvement (fat loss, lean mass support)
— Recovery from training
— Sleep quality (GH is primarily released during slow-wave sleep)
— Anti-aging / longevity protocols

Key distinctions within GHS: ipamorelin is a selective ghrelin receptor agonist with a cleaner pulse profile and fewer appetite/cortisol effects than GHRP-2 or GHRP-6. CJC-1295 is a GHRH analog — it extends the GH release pulse rather than triggering a new one. Ipamorelin and CJC-1295 are often used together because they work through complementary mechanisms (ghrelin pathway + GHRH pathway). Sermorelin is a truncated GHRH analog — it was the original FDA-approved GHRH-class drug and is widely used in compounded form. For a detailed comparison, see sermorelin vs ipamorelin vs CJC-1295.

2. Repair and Recovery Peptides
BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4) are the two most widely used repair peptides. BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice; it has strong preclinical evidence for tendon, ligament, gut, and neurological repair via angiogenesis promotion and growth factor upregulation. TB-500 (the active fragment of Thymosin Beta-4) promotes cell migration, reduces inflammation, and supports tissue repair — particularly in muscle, tendon, and cardiac tissue.
These are often used for:
— Orthopedic injuries (tendons, ligaments, joints)
— Gut healing and GI permeability issues
— Post-surgical recovery
— Chronic inflammation

See BPC-157 and TB-500 compared and BPC-157 for gut healing for detailed guides.

3. Metabolic / GLP-1 Peptides
GLP-1 receptor agonists (semaglutide, tirzepatide) are technically peptides — they mimic glucagon-like peptide-1, a naturally occurring gut-derived hormone that regulates appetite and insulin secretion. These have the most robust clinical trial evidence of any therapeutic peptide category (the STEP and SURMOUNT trials show 15–22% body weight loss at maximum doses). They require ongoing use and are appropriate for:
— Weight loss in overweight/obese individuals
— Metabolic syndrome and insulin resistance
— Men combining GLP-1 therapy with TRT (see GLP-1 and TRT)

4. Sexual Health Peptides
PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder in women (as Vyleesi) and is widely prescribed off-label for men. It acts on melanocortin receptors in the brain — the central arousal pathway — rather than the vascular mechanism of PDE5 inhibitors like sildenafil. This makes it useful for men whose ED has a central/libido component rather than a purely vascular one, and for men who do not respond to or cannot use PDE5 inhibitors. See PT-141 benefits and dosage guide.

5. Longevity and Immune-Modulating Peptides
This category includes epithalon (a tetrapeptide that activates telomerase), thymosin alpha-1 (an immune modulator), and related compounds. Evidence is thinner and more preclinical than GHS or GLP-1 peptides. They are used in longevity protocols by practitioners willing to work in more evidence-limited territory.

6. Nootropic Peptides
Semax and Selank (Russian-developed peptides with anxiolytic and cognitive-enhancing effects) are available in some US compounding contexts but are less widely prescribed than the categories above. Evidence base is largely from Russian clinical trials, with limited Western replication. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: starting with a complex multi-peptide stack as a beginner. Clinical experience consistently shows that beginners who add multiple variables simultaneously cannot identify which peptide is responsible for effects (positive or negative) and make suboptimal protocol decisions as a result. One peptide, one outcome target, observe for 8–12 weeks. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Who is a good candidate for peptide therapy?

Peptide therapy is not for everyone. The best candidates are adults with a clear, specific health goal that aligns with the evidence base for a specific peptide — who work with a physician rather than self-directing. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Strong candidate profiles by peptide category:

Growth Hormone Secretagogues (GHS):
— Adults 35+ noticing declining recovery, reduced sleep quality, or body composition changes consistent with age-related GH decline
— Men and women with confirmed low IGF-1 on labs (a reasonable proxy for GH axis activity)
— People with body composition goals not being met by training and nutrition alone
— NOT appropriate for: active cancer or cancer history (GH stimulation is contraindicated), uncontrolled diabetes, Prader-Willi syndrome, or active acromegaly

BPC-157 / TB-500 (Repair Peptides):
— Adults with specific musculoskeletal injuries (tendon, ligament, joint) that are healing slowly
— People with GI conditions including increased intestinal permeability, inflammatory bowel issues, or slow GI motility
— Post-surgical recovery patients in consultation with their surgeon
— NOT appropriate for: uncontrolled autoimmune conditions (limited data on immune modulation effects), active infection

GLP-1 Agonists (Semaglutide/Tirzepatide):
— Adults with BMI ≥30, or BMI ≥27 with a weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia)
— Individuals who have not achieved adequate weight loss through lifestyle modification
— NOT appropriate for: personal or family history of medullary thyroid carcinoma or MEN2, hypersensitivity to GLP-1 class drugs, active pancreatitis

PT-141 (Sexual Health):
— Men with erectile dysfunction or reduced libido that has a central/neurological component (not purely vascular)
— Men who have not responded to or cannot use PDE5 inhibitors
— NOT appropriate for: uncontrolled hypertension (acute BP increase possible), cardiovascular disease without physician clearance

General disqualifying factors for any peptide therapy:
— Active cancer or recent cancer history (discuss with oncologist)
— Pregnancy or breastfeeding
— Lack of access to monitoring (labs, follow-up) — peptide therapy without appropriate monitoring is not responsible medicine
— Unwillingness to work with a licensed clinician — self-directed peptide use from unregulated sources carries meaningfully higher risk A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: beginning peptide therapy without baseline labs. You cannot meaningfully evaluate whether a protocol is working — or whether it is causing harm — without a baseline to compare against. A reputable clinic will always require labs before initiating a protocol. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

How much does peptide therapy cost in 2026?

Peptide therapy costs vary substantially by category, clinic model, and protocol complexity. Headline pricing from clinic websites is almost always incomplete — the real number includes medication, labs, consultations, and refills over the full protocol length. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

A realistic 2026 cost breakdown by category:

Growth Hormone Secretagogues (3–6 month protocol):
— Medication: $100–$250/month (ipamorelin, CJC-1295, or sermorelin via compounding pharmacy)
— Initial consultation: $100–$300 (one-time or included in membership)
— Labs (IGF-1, CBC, CMP, GH stimulation if ordered): $100–$300 one-time, then every 3–6 months
— Follow-up consultations: $50–$150/quarter or included in subscription
— Realistic 6-month total: $900–$2,200

BPC-157 / TB-500 (8–12 week protocol):
— Medication: $80–$200/month
— Consultation: $100–$250 one-time
— Labs: minimal for short-course injury protocols ($50–$150)
— Realistic 10-week total: $500–$1,200

GLP-1 Agonists (6–12+ month ongoing):
— Compounded semaglutide: $100–$250/month
— Compounded tirzepatide: $150–$350/month
— Branded versions (Wegovy/Zepbound): $400–$700/month without insurance
— Consultation + labs: $150–$400 initial, then quarterly
— Realistic annual cost: $1,800–$6,000+ depending on drug and clinic model

PT-141 (as-needed or short course):
— Medication: $80–$200 per supply (often sold per dose or per vial)
— Consultation: $100–$200
— Realistic short-course total: $300–$600

What drives the cost differences between clinics:
1. Clinic model (subscription vs pay-per-visit)
2. Compounding pharmacy partner (quality and pricing vary significantly)
3. Protocol complexity (single peptide vs combination stack)
4. Lab requirements (some clinics require extensive panels; others are minimal)
5. Provider access model (assigned clinician vs message-only support)

The key mistake beginners make is comparing month-one promotional pricing. Many clinics offer discounted or free first-month pricing that jumps significantly in month two or three. Always ask for the full 6-month cost before enrolling.

For detailed cost guides by peptide: sermorelin cost guide and BPC-157 cost guide. For clinic comparisons: best online peptide clinics 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: enrolling in a 3-month commitment based on a promotional first-month price without understanding the ongoing cost structure. Peptide therapy works on longer timelines — a 3-month protocol often shows early signals, but meaningful results in body composition or recovery typically take 4–6 months. Budget for the full protocol, not just the first shipment. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Is peptide therapy safe? Risks, side effects, and what to watch for

Peptide therapy safety varies significantly by category and delivery method. The most commonly prescribed therapeutic peptides have solid safety records when prescribed by licensed physicians with appropriate monitoring — but risks exist and are worth understanding before you start. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Category-specific safety profiles:

Growth Hormone Secretagogues:
Common side effects: water retention, mild joint discomfort, elevated hunger (especially with ghrelin-pathway peptides like GHRP-6 — less so with ipamorelin), injection site reactions, vivid dreams or sleep changes in the first weeks. Serious concerns: carpal tunnel symptoms at high IGF-1 levels (dose-related and reversible), theoretical concern about stimulating pre-existing undetected cancer (contraindicated in active cancer history). Monitoring requirement: IGF-1 at baseline and every 3–6 months to ensure levels stay within physiological range.

BPC-157 and TB-500:
Generally excellent short-term safety profile in animal and human case data. Common effects: mild GI discomfort (especially with oral BPC-157), nausea at high doses, injection site reactions. Less understood: long-term use data is limited because most clinical use is short-course (4–12 weeks). Theoretical concern: angiogenesis promotion by BPC-157 raises theoretical questions about tumor vascularity if undetected cancer is present — the same caution that applies to GHS peptides.

GLP-1 Agonists:
This category has the most robust safety data because semaglutide and tirzepatide are FDA-approved medications with large clinical trial databases. Common side effects: nausea, vomiting, diarrhea, constipation (especially during dose escalation — typically improves after 4–8 weeks). Serious but rare: pancreatitis, gallbladder disease (10–15x increased risk with rapid weight loss). Contraindicated: MTC/MEN2 history (regulatory concern; direct causal link unproven in humans).

PT-141:
FDA-approved safety profile (approved as Vyleesi). Common: nausea (40%+ in trials), flushing, headache, transient blood pressure increase. The BP effect is the main clinical concern for patients with cardiovascular disease — this is a real contraindication, not a theoretical one.

What separates safe from risky peptide therapy:
1. Physician oversight: legitimate medical consultation vs 'click to buy' without a real prescription
2. Compounding pharmacy quality: 503A/503B registered vs unregulated sources (which may have contamination, dosing inaccuracy, or contain different compounds entirely)
3. Monitoring cadence: baseline labs + follow-up vs no labs ever
4. Contraindication screening: a real intake form and clinical history review vs no screening

The highest-risk scenario in peptide therapy is not a legitimate clinic — it is buying unregulated peptides from research vendors and self-administering without physician oversight. This is common, and it carries risks that legitimate clinical peptide therapy does not.

For a comprehensive safety guide: peptide therapy side effects and safety. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: using research-grade peptides from unregulated vendors under the assumption that 'peptides are natural and safe.' The peptide category itself may have a good safety profile — but unregulated manufacturing introduces contamination, inaccurate dosing, and the absence of any legitimate medical oversight. This is where the real safety risk lives. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

How to get started: the right sequence for a beginner

Most beginners get the order of operations wrong — they research peptides and pick what sounds good, then find a clinic to write the prescription. The right sequence is the reverse: start with your health goal, identify the evidence-supported peptide category, then evaluate clinics that specialize in that category. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The correct beginner sequence:

Step 1: Define one primary goal in one sentence.
Not 'optimize my health' or 'feel better' — one specific, measurable target. 'Reduce recovery time from strength training and improve sleep quality.' 'Accelerate healing of a chronic Achilles tendon injury.' 'Lose 30 lbs of fat while preserving muscle on a concurrent TRT protocol.' One goal, one evidence pathway, one peptide category to start.

Step 2: Research the evidence for the peptide category that addresses your goal.
Before your first clinic consultation, read the evidence summary for the peptides most likely to be prescribed. Understand what the evidence shows (and what it does not show). Know the common side effects. Know the contraindications. A patient who walks into a consultation already knowing the basics gets a much better consultation than one who is hearing everything for the first time.

Step 3: Get baseline labs.
Before any clinic consultation, run your baseline labs. At minimum: CBC, comprehensive metabolic panel (CMP). Add IGF-1 if you are pursuing GHS peptides. Add testosterone panel if there is any men's health component. Some clinics require specific labs before they will consult — getting them first speeds up the process and gives you independent baseline data not attached to the clinic's records.

Step 4: Evaluate and choose a clinic.
See the next section for how to evaluate clinics specifically. Key minimum requirements: licensed physician consultation (not PA-only for complex cases), 503A or 503B compounding pharmacy partner, a defined monitoring protocol, and transparent pricing for the full protocol duration.

Step 5: Start simple, observe systematically.
Your first protocol should have one or two peptides maximum. Track one outcome variable weekly (sleep quality score, weekly recovery rating, body composition photo + measurement, injury pain scale). Keep a simple log. This is how you generate evidence from your own body to optimize the protocol — and how you identify early side effects before they become problems.

Step 6: Reassess at 8–12 weeks.
GHS peptides typically show first effects on sleep and recovery within 4–6 weeks; body composition effects are visible by weeks 8–12. BPC-157 for injuries often shows meaningful signal within 4–6 weeks. GLP-1 weight loss effects are visible within 4 weeks but meaningful body composition results take 12–24 weeks. Reassess your protocol against your baseline data at 8–12 weeks before making any changes. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: beginning peptide therapy without a tracking system. 'Feeling better' is not measurable enough to know whether the peptide is working or whether the placebo effect is doing the work. One clear outcome metric, tracked weekly, is the minimum viable evidence base for a protocol decision. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

How to choose a peptide clinic: what to look for and what to avoid

The peptide telehealth space in 2026 has excellent clinics and deeply problematic ones. The difference between a good and bad clinic almost never shows up in the first month — it shows up in the follow-up, protocol adjustment, and refill reliability after onboarding friction appears. Buyers searching for peptide therapy beginners guide usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

What a legitimate peptide clinic looks like:

✅ Real physician consultation — a licensed MD or DO with men's health or functional medicine background reviews your labs and history before prescribing. PA-only consultations are acceptable for straightforward cases but should escalate to physician for complex protocols.
✅ 503A or 503B compounding pharmacy — the clinic uses a named, verifiable registered compounding pharmacy. Ask for the pharmacy name and verify it is on the FDA's 503B database or your state's 503A registry.
✅ Required baseline labs — the clinic will not proceed without labs. Any clinic that prescribes peptides without reviewing your bloodwork is not practicing legitimate medicine.
✅ Defined monitoring cadence — you receive a clear protocol: recheck labs at [timeline], follow-up consultation at [timeline], here is how we adjust dose if [outcome].
✅ Transparent full-protocol pricing — they will give you a 6-month all-in cost without making you extract it question by question.
✅ Clinician continuity — you interact with the same clinician (or small team) who knows your case, not a different provider each visit.

Red flags to eliminate immediately:

❌ No required labs — this is a complete disqualifier. Walk away.
❌ No real physician — scripted consultations with no medical license verification, or 'AI-assisted prescribing' without physician sign-off.
❌ Unknown compounding pharmacy — can't name it, won't name it, or the name doesn't appear on any regulatory database.
❌ Guaranteed outcomes in marketing — legitimate medicine does not guarantee individual outcomes. Clinics that promise specific results are making promises they cannot keep.
❌ No refund or cancellation policy — long prepayment requirements with no clear exit terms are a structural incentive for poor follow-up service.
❌ No response to specific clinical questions — ask your intake coordinator a specific clinical question about your protocol. If the answer is vague, templated, or avoids the question entirely, that is signal about how the clinic operates after onboarding.

For a comparison of the most reputable clinics in 2026: best online peptide clinics 2026. For TRT + peptide combined protocols: best online TRT clinics compared. Use the PeakedLabs provider comparison tool to compare clinics on the variables that actually predict outcome quality. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: choosing a clinic based on the lowest first-month price. Peptide therapy quality is almost entirely determined by what happens after month one — the refill reliability, the follow-up consultation quality, the willingness to adjust the protocol when results do not match expectations. These are the variables that matter and are not visible in promotional pricing. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

Not sure which peptide clinic is right for your goals? Use the PeakedLabs provider comparison tool to evaluate clinics side by side on the variables that predict outcome quality — monitoring cadence, compounding pharmacy partner, physician access, and 6-month cost.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

What is peptide therapy used for?

Peptide therapy is used for a wide range of goals including body composition improvement, recovery acceleration, tissue healing (tendons, ligaments, gut), weight loss, sexual health, immune modulation, and longevity. Different peptide categories address different goals — growth hormone secretagogues for body composition and sleep, BPC-157 and TB-500 for repair and recovery, GLP-1 agonists for weight loss, and PT-141 for sexual health.

Is peptide therapy safe?

Peptide therapy has a good safety profile when prescribed by licensed physicians with appropriate monitoring and dispensed by a legitimate 503A or 503B compounding pharmacy. The risks increase significantly with self-directed use of unregulated research peptides without physician oversight. Common side effects for the most prescribed peptides (GHS, BPC-157, GLP-1) are generally mild and dose-adjustable.

Do you need a prescription for peptide therapy?

Yes — legitimate therapeutic peptides in the US require a physician's prescription and must be dispensed by a licensed compounding pharmacy. Any source that sells therapeutic peptides without a prescription and genuine physician consultation is operating outside legal and regulatory standards. See our guide on whether you need a prescription for peptides for the full regulatory breakdown.

How long does it take to see results from peptide therapy?

Timeline varies by peptide category: GLP-1 agonists produce weight changes within 4 weeks, with significant results at 12–24 weeks. GHS peptides (ipamorelin, sermorelin, CJC-1295) often improve sleep and recovery within 4–6 weeks; body composition effects are visible at 8–12 weeks. BPC-157 for injuries often shows meaningful signal in 4–6 weeks. See our full guide on how long peptide results take.

What are the best peptides for beginners?

The most commonly prescribed first peptides for beginners are ipamorelin (alone or combined with CJC-1295 no-DAA) for growth hormone optimization and sleep/recovery improvement, and BPC-157 for injury or gut healing. GLP-1 agonists (semaglutide, tirzepatide) are the best-evidenced option if weight loss is the primary goal. Beginners should start with one peptide or one established combination — not a multi-peptide stack.

How much does peptide therapy cost per month?

Monthly medication costs for common peptide protocols in 2026: ipamorelin or sermorelin $100–$200/month; BPC-157 $80–$180/month; compounded semaglutide $100–$250/month; compounded tirzepatide $150–$350/month; PT-141 $80–$200 per supply. Add $50–$150/month for clinic fees, consultations, and labs. A realistic 6-month GHS protocol totals $900–$2,200 all-in.

What is the difference between peptides and steroids?

Steroids (anabolic-androgenic steroids) override the body's hormonal system with exogenous hormones — they suppress natural production and carry significant long-term side effect risks. Most therapeutic peptides instead amplify signals the body already produces, working through the body's own feedback mechanisms rather than bypassing them. Growth hormone secretagogues, for example, stimulate the pituitary to release its own GH rather than replacing GH with exogenous hormone.

Can peptide therapy be combined with TRT?

Yes — combining GHS peptides (ipamorelin, sermorelin, CJC-1295) with TRT is a common clinical approach in men's health. GHS peptides address the GH axis while TRT addresses the testosterone axis — they work through complementary pathways without significant interactions. GLP-1 agonists can also be combined with TRT, though they require adjusted monitoring of testosterone and estradiol as body composition changes. See our GLP-1 and TRT guide for details.

How do I know if a peptide clinic is legitimate?

Key legitimacy markers: licensed physician (MD/DO) conducts your consultation, the clinic requires baseline labs before prescribing, medication is compounded by a named 503A or 503B registered pharmacy, you receive a defined monitoring schedule, and pricing is transparent for the full protocol duration. Major red flags: no required labs, unknown or unnamed compounding pharmacy, guaranteed outcome claims, no real physician sign-off on prescriptions.

Are peptides FDA-approved?

Some therapeutic peptides are FDA-approved drugs: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), PT-141 (Vyleesi), and tesamorelin (Egrifta). Others — including ipamorelin, CJC-1295, BPC-157, and TB-500 — are prescribed as compounded medications under physician orders, not as FDA-approved drugs. The distinction matters for insurance coverage, pricing, and regulatory status. A legitimate clinic will be clear about which category applies to your prescribed peptide.

What labs do I need before starting peptide therapy?

Minimum baseline labs before starting any peptide protocol: CBC (complete blood count) and CMP (comprehensive metabolic panel). For GHS peptides: add IGF-1. For any men's health overlap: add total testosterone, free testosterone, and estradiol. For GLP-1 protocols: add HbA1c and fasting glucose. A clinic that does not require labs before prescribing peptides is a clinic to avoid.